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ABSTRACT
Background: The expression levels of CT10 regulator of kinase (Crk) and Crk-like
(CrkL) are elevated in many human cancers, including glioblastoma (GBM), and are
believed to contribute to poor prognosis. Although Crk and CrkL have been
proposed as therapeutic targets in these tumors, the lack of a reliable, quantitative
assay to measure Crk and CrkL activity has hindered the development of inhibitors.

Result 1. Single and double knockdown of Crk and CrkL
using siRNAs in human glioblastoma cells

Result 3. CrkL overexpression rescues
the inhibitory effects induced by Crk/CrkL knockdown

Methods: Here, we knocked down Crk, CrkL, or both using small interfering RNAs
(siRNAs) in a human GBM cell line, U-118MG, to determine the respective,
quantitative contributions of Crk and CrkL to cellular phenotypes.
Results: The combined use of specific and potent Crk and CrkL siRNAs induced
effective knockdown of CrkII, CrkI, and CrkL. Whereas Crk knockdown did not
affect cell morphology, proliferation, adhesion, or invasion, CrkL knockdown
caused shrinkage of cells and inhibition of cell proliferation, adhesion, and
invasion. Crk/CrkL double knockdown resulted in more pronounced morphological
alterations and more robust inhibition of proliferation, adhesion, and invasion.
Furthermore, Crk/CrkL double knockdown completely blocked cell migration, and
this effect was rescued by transient overexpression of CrkL but not of Crk.
Quantification of protein levels indicated that CrkL is expressed more abundantly
than CrkII and CrkI in U-118MG cells.
Conclusions/Significances: These results demonstrate both the predominant role
of CrkL and the essential overlapping functions of Crk and CrkL in U-118MG cells.
Furthermore, our study indicates that migration of U-118MG cells depends entirely
on Crk and CrkL. Thus, impedance-based, real-time measurement of tumor cell
migration represents a robust assay for monitoring Crk and CrkL activities.
Support: This work was supported by Tom Keaveny Endowed Fund for Pediatric
Cancer Research (to TP) and by an MCA Partners Advisory Board grant from
Children’s Mercy Hospital (CMH) and the University of Kansas Cancer Center
(KUCC) (to TP).

INTRODUCTION
By mediating protein-protein interactions through their SH2 and SH3 domains, Crk and CrkL play
essential roles in signal transduction pathways. Crk and CrkL are expressed ubiquitously, and they
have been implicated in diverse biological processes. Crk and CrkL mediate cytoskeletal changes, cell
proliferation, adhesion, migration, differentiation, phagocytosis, and pathogen uptake that are
induced by growth factors, tyrosine kinase-coupled receptors, cytokines, integrins, mechanical force,
and pathogens.
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Crk and CrkL play critical roles in tumor cell migration and invasion in a variety of cancers. In most of
these studies, loss of either Crk or CrkL resulted in decreases in tumor cell migration and invasion,
suggesting that tumor cell migration and invasion are highly demanding cellular processes that
require both Crk and CrkL to reorganize the cellular cytoskeletal network. In particular, both Crk and
CrkL have been demonstrated to be important for tumor cell migration and invasion in colorectal
cancer, glioblastoma, ovarian cancer, cervical cancer, gastric cancer, and hepatocellular carcinoma

A. U-118MG cells were electroporated with non-targeting siRNA (NT1) (80 pmol), Crk siRNA 10 (40
pmol), CrkL siRNAs 22 (20 pmol) plus 24 (20 pmol), or with Crk and CrkL siRNAs together. The cells
were harvested and re-plated at 3 days post transfection (DPT), and total cell lysates were prepared at
4 DPT for Western blot analyses. Protein levels upon siRNA transfection were compared with NT1.
Alpha-tubulin and vinculin levels were measured as controls. B. Protein bands were quantified using
the Odyssey system, calculated as percentages of the control (NT1), and their mean ± SD values are
shown. *p < 0.05, **p < 0.01, compared with NT1. C. Proliferation of U-118MG cells electroporated
with Crk and CrkL siRNAs after re-plating at 3 DPT was quantitatively measured using WST-1. The A450690 values are presented in the logarithmic scales. D. Exponential trendlines for the WST-1 assay
graphs were drawn and their slopes, the coefficients of x, are presented as the rates for exponential
cell growth. E. After cells were transfected with Crk and CrkL siRNAs followed by re-plating at 3 DPT,
phase-contrast images of live cells were taken at 4 DPT using the EVOS system. Representative images
are shown. Scale bar: 400 µm.

U-118MG cells were first electroporated with Crk siRNA 10 (40 pmol) and CrkL siRNAs 22 (20 pmol)
plus 24 (20 pmol) together. At 3 DPT, the cells were harvested, electroporated again with synRNA of
Flag-tagged CrkII, CrkI, or CrkL, and re-plated for the various assays. A. At 4 DPT, total cell lysates were
obtained for Western blot analyses. Vinculin levels were measured as controls. B. Protein bands were
quantified using the Odyssey system, calculated as percentages of the control (None) signal, and their
mean ± SD values are shown. Inset. Protein bands detected with anti-Flag antibody were quantified,
calculated as percentages of the maximal signal (dKD + CrkL-Flag), and their mean ± SD values are
shown. C. Proliferation of U-118MG cells electroporated first with siRNAs and then again with synRNA
was quantitatively measured using WST-1. The A450-690 values are presented in the logarithmic scales.
D. Exponential trendlines for the WST-1 assay graphs were drawn and their slopes, the coefficients of
x, are presented as the rates for exponential cell growth. *p < 0.05, compared with double knockdown
only. E-G. U-118MG cells electroporated first with siRNAs and then again with synRNA were plated
onto an E-Plate 16, and two CIM-Plate 16 without and with Matrigel coating for cell adhesion (E),
migration (F), and invasion (G) using the xCELLigence system. Cell index values were obtained from 4
wells for each sample, and their mean ± SD values are shown.

Result 4. More abundant expression of CrkL
in human glioblastoma cells

Result 2. Inhibition of cell adhesion, migration, and invasion
by Crk and CrkL knockdown
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Higher expression of Crk and CrkL in cancer
tissues has been reported to contribute to
poor prognosis and lower survival of
patients in many cancer types.
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U-118MG cells were electroporated with NT1 (80 pmol), Crk siRNA 10 (40 pmol), CrkL siRNAs 22 (20
pmol) plus 24 (20 pmol), or with Crk and CrkL siRNAs together. At 3 DPT, the cells were harvested and
plated onto an E-Plate 16, and two CIM-Plates without and with Matrigel coating for cell adhesion (A),
migration (B), and invasion (C) using the xCELLigence system according to the Experimental
Procedures. Cell index values were obtained from 4 wells for each sample, and their mean ± SD
values are shown. Three independent experiments were carried out, and the results were
reproducible.

A-C. Crk and CrkL proteins were detected using anti-Crk (A and C) or anti-CrkL (B) antibodies from
three different lysates prepared from U-118MG cells without any transfection (5 µg per lane). The
indicated concentrations (ng) of purified proteins (A: CrkII-Flag, B: CrkL-Flag, and C: CrkI-Flag) were
loaded together as the standard proteins. Endogenous Crk and CrkL proteins are marked in red.
Purified proteins are marked in blue. F. For each Western blot image, protein bands were quantified
using the Odyssey system, a standard curve was drawn for the purified protein, and a fourth-order
polynomial trendline was obtained using the Microsoft Excel program. The trendline was used to
determine the protein concentrations in the cell lysates. G. U-118MG cells were plated onto 35 mm
dishes with similar densities to those for Western blot experiments. One day later, both the cell
numbers and the total protein amounts were determined, and the mean of the total protein per cell
was calculated to be 536 pg. This number was used to estimate the cell numbers for the U-118MG cell
lysates that were prepared without counting. Protein molecular weights were calculated on
http://web.expasy.org/protparam/. Then, the numbers of the protein molecules per cell were
calculated. D-E. The indicated concentrations (ng) of purified Flag-tagged Crk and CrkL proteins were
detected using an anti-Flag antibody. H-I. Protein bands for Flag-tagged Crk and CrkL proteins were
quantified using the Odyssey system, and their mean ± SD values are shown in logarithmic scales.

